Author | No | Patients | Size | Invasive | Subtype | T stagea | Survival | |
---|---|---|---|---|---|---|---|---|
Noninvasive | Invasive | |||||||
Adsay et al. [5] 2012 | 123 | F/M: 2/1 Mean age: 61Â years | 2.6Â cm | 44.7Â % | Biliary: 50Â % Gastric: 36Â % Intestinal: 10.8Â % Oncocytic: 8.6Â % | T1: 32Â % T2: 47Â % T3: 21Â % | 1Â year: 90Â % 3Â years: 90Â % 5Â years: 58Â % | 1Â year: 69Â % 3Â years: 60Â % 5Â years: 60Â % |
Isozaki et al. [8] 2014 | 23 | F/M: 9/14 Mean age: 69Â years | 2.8Â cm | 39.1Â % | Biliary: 56.5Â % Gastric: 34.7Â % Intestinal: 8.7Â % | T1: 36Â % T2: 50Â % T3: 14Â % | 3Â years: 91Â % 5Â years: 67Â % | |
Bennet et al. [9] 2015 | 7 | F/M: 6/1 Mean age: 68Â years | 6.2Â cm | 42.9Â % | Biliary: 71.4Â % Gastric: 14.2Â % Intestinal: 14.2Â % | T1: 25Â % T2: 25Â % T3: 50Â % | 3Â years: 71Â % 5Â years: 58Â % |